These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7136849)

  • 1. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues.
    Shinozawa S; Fukuda T; Araki Y; Oda T
    Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse.
    Shinozawa S; Araki Y; Oda T
    Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H; Takahashi H; Miyamoto K; Uchida T; Tokiwa T
    Cancer Chemother Pharmacol; 1996; 38(5):417-24. PubMed ID: 8765434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography.
    Shinozawa S; Oda T
    J Chromatogr; 1981 Aug; 212(3):323-30. PubMed ID: 7263801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography.
    Shinozawa S; Mimaki Y; Araki Y; Oda T
    J Chromatogr; 1980 Aug; 196(3):463-9. PubMed ID: 7430305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
    Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
    Ehninger G; Stocker HJ; Proksch B; Wilms K
    Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of macromolecular conjugate, adriamycin linked to oxidized dextran, in rat and mouse bearing tumor cells.
    Munechika K; Sogame Y; Kishi N; Kawabata Y; Ueda Y; Yuamanouchi K; Yokoyama K
    Biol Pharm Bull; 1994 Sep; 17(9):1193-8. PubMed ID: 7531053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.
    Cervato G; Viani P; Galatulas I; Bossa R; Cestaro B
    Anticancer Res; 1986; 6(6):1287-90. PubMed ID: 3813484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect of a water-in-oil-in-water type adriamycin emulsion on Ehrlich solid tumor-bearing mice].
    Mimaki Y; Shinozawa S; Yasuda K; Yao K; Etwo K; Fukuda T; Araki Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):467-72. PubMed ID: 7184409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
    Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
    Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoural injection of calcium channel blocker enhances cytotoxicity of adriamycin in Ehrlich ascites solid tumour.
    Matsuoka H; Sugimachi K; Kuwano H; Yano K
    Eur J Surg Oncol; 1989 Jun; 15(3):224-31. PubMed ID: 2737309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H; Iguchi H; Tone H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high dose alpha-tocopherol acetate on the toxicity and tissue distribution of adriamycin (doxorubicin).
    Shinozawa S; Gomita Y; Araki Y
    Acta Med Okayama; 1988 Oct; 42(5):253-8. PubMed ID: 3223337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and metabolism of a new anthracycline-containing fluorine (ME2303) in Lewis lung carcinoma-bearing mice.
    Iigo M; Hoshi A; Kadosawa H; Fujigaki M
    Jpn J Cancer Res; 1991 Nov; 82(11):1317-21. PubMed ID: 1752788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.